New York: Saxenda litigation | DrugsMonitor.com

Saxenda litigation in New York (NY): Allegations recap, procedure at a glance, next steps—not legal advice.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes., New York